Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INCCPIX · Entity 6757 | Director · Chairman and CEO · 10% owner | March 18, 2026 | March 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CUMBERLAND PHARMACEUTICALS INC
Report date March 18, 2026 · Filed March 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.80 · Expires 2036-03-18 | Direct | 568,000 |
Reported balance
After 2026-03-18 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-03-18 · Grant · Acquired 100,000 · Balance 568,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 30, 2019 Filed Jun 14, 2019 21:21 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 27 | $6.37 | $171.99 |
DisclosureSEC source: 0001209191-19-037201 · doc4.xml · nonDerivative · entry 6 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,761,077 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| April 26, 2019 Filed Jun 14, 2019 21:21 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 14 | $6.32 | $88.48 |
DisclosureSEC source: 0001209191-19-037201 · doc4.xml · nonDerivative · entry 5 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,761,050 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| April 25, 2019 Filed Jun 14, 2019 21:21 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 24 | $6.17 | $148.08 |
DisclosureSEC source: 0001209191-19-037201 · doc4.xml · nonDerivative · entry 4 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,761,036 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| April 24, 2019 Filed Jun 14, 2019 21:21 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 32 | $6.04 | $193.28 |
DisclosureSEC source: 0001209191-19-037201 · doc4.xml · nonDerivative · entry 3 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,761,012 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| April 17, 2019 Filed Jun 14, 2019 21:21 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 81 | $6.21 | $503.01 |
DisclosureSEC source: 0001209191-19-037201 · doc4.xml · nonDerivative · entry 2 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,760,980 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| April 12, 2019 Filed Jun 14, 2019 21:21 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 99 | $6.32 | $625.68 |
DisclosureSEC source: 0001209191-19-037201 · doc4.xml · nonDerivative · entry 1 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,760,899 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| April 09, 2019 Filed Apr 12, 2019 21:16 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 60 | $6.41 | $384.60 |
DisclosureSEC source: 0001209191-19-024500 · doc4.xml · nonDerivative · entry 6 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,760,800 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| April 05, 2019 Filed Apr 12, 2019 21:16 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 183 | $6.32 | $1,156.56 |
DisclosureSEC source: 0001209191-19-024500 · doc4.xml · nonDerivative · entry 5 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,760,740 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| April 04, 2019 Filed Apr 12, 2019 21:16 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 241 | $6.19 | $1,491.79 |
DisclosureSEC source: 0001209191-19-024500 · doc4.xml · nonDerivative · entry 4 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,760,557 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| April 03, 2019 Filed Apr 12, 2019 21:16 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 80 | $6.00 | $480.00 |
DisclosureSEC source: 0001209191-19-024500 · doc4.xml · nonDerivative · entry 3 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,760,316 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| April 02, 2019 Filed Apr 12, 2019 21:16 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 580 | $6.12 | $3,549.60 |
DisclosureSEC source: 0001209191-19-024500 · doc4.xml · nonDerivative · entry 2 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,760,236 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| April 01, 2019 Filed Apr 12, 2019 21:16 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 382 | $5.99 | $2,288.18 |
DisclosureSEC source: 0001209191-19-024500 · doc4.xml · nonDerivative · entry 1 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,759,656 F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Read SEC document |
| March 22, 2019 Filed Mar 22, 2019 21:21 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | Tax withholdingCommon Stock | 46,623 | $5.62 | $262,021.26 |
DisclosureSEC source: 0001209191-19-021046 · doc4.xml · nonDerivative · entry 2 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,759,274 F2 · shares: This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares. Read SEC document |
| March 22, 2019 Filed Mar 22, 2019 21:21 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | GrantCommon Stock | 100,000 | $5.98 | $598,000.00 |
DisclosureSEC source: 0001209191-19-021046 · doc4.xml · nonDerivative · entry 1 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,805,897 F1 · shares: Restricted stock award will vest 100% on March 18, 2023. Read SEC document |
| August 30, 2018 Filed Aug 31, 2018 21:14 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | GiftCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-049111 · doc4.xml · nonDerivative · entry 1 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,705,897 F1 · shares: Represents a share transfer to a family trust with other beneficial owners. Read SEC document |
| March 23, 2018 Filed Mar 23, 2018 21:44 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | Tax withholdingCommon Stock | 24,373 | $6.70 | $163,299.10 |
DisclosureSEC source: 0001209191-18-021478 · doc4.xml · nonDerivative · entry 2 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,905,897 F2 · shares: This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares. Read SEC document |
| March 23, 2018 Filed Mar 23, 2018 21:44 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | GrantCommon Stock | 100,000 | $6.70 | $670,000.00 |
DisclosureSEC source: 0001209191-18-021478 · doc4.xml · nonDerivative · entry 1 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,930,270 F1 · shares: Restricted stock award will vest 100% on March 20, 2022. Read SEC document |
| April 07, 2017 Filed Apr 7, 2017 20:55 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | Tax withholdingCommon Stock | 13,575 | $6.45 | $87,558.75 |
DisclosureSEC source: 0001209191-17-026304 · doc4.xml · nonDerivative · entry 2 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,845,270 F2 · shares: This transaction represents shares withheld by the Company to cover the tax withholding obligations for the vesting of 50,000 shares during March 2017. Read SEC document |
| April 07, 2017 Filed Apr 7, 2017 20:55 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | GrantCommon Stock | 100,000 | $6.45 | $645,000.00 |
DisclosureSEC source: 0001209191-17-026304 · doc4.xml · nonDerivative · entry 1 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,858,845 F1 · shares: Restricted stock award will vest 100% on March 17, 2021. Read SEC document |
| December 22, 2015 Filed Dec 22, 2017 22:01 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | GiftCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-067091 · doc4.xml · nonDerivative · entry 1 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,830,270 F1 · shares: Transaction is a charitable donation Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.